
Monday, August 24, 2020 11:00 a.m.–12:00 p.m. ET Register: https://us02web.zoom.us/j/82511967079?pwd=SUo5WG1rWG9aNGd4ZHUrQWQ0WDhTdz09 This presentation will address different approaches that successfully develop an anti-immune checkpoint antibody and other antibodies licensed to Pharma companies and in ongoing clinical trials. Other approaches under development will also be addressed. Register today to join us for this timely and informative presentation. Speakers: David Blum, Ph.D. Director, Bioexpression and Fermentation Facility Director, Master of Biomanufacturing and Bioprocessing University of Georgia Laura Bover, PhD Professor Depts. of Genomic Medicine/Immunology Director Monoclonal Antibodies Core Facility Steering Committee of the Immunology Program GSBS (Graduate School of Biomedical Sciences at Houston) University of Texas M.D. Anderson Cancer Center